Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000362950

Medchemexpress LLC Inolitazone dihydrochloride | 223132-38-5 | 98.45% | 575.51 | 25 MG
SDP

Catalog No. 5000362950
Encompass_Preferred

Inolitazone dihydrochloride is a novel high-affinity PPARγ agonist that is dependent upon PPARγ for its biological activity. It upregulates the cell cycle kinase inhibitor, p21WAF1/CIP1, and has shown additive antiproliferative activity in cell culture in combination with Paclitaxel. It inhibits tumor growth in athymic nude mice in a dose-responsive manner.

  • High-affinity PPARγ agonist
  • Upregulates p21WAF1/CIP1 cell cycle kinase inhibitor
  • Shows additive antiproliferative activity with Paclitaxel
  • Inhibits tumor growth in vivo

Catalog No. 50-003-62950 Supplier Medchemexpress LLC Supplier No. 25MGHY14792B
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Inolitazone dihydrochloride is a novel high-affinity PPARγ agonist that is dependent upon PPARγ for its biological activity. It upregulates the cell cycle kinase inhibitor, p21WAF1/CIP1, and has shown additive antiproliferative activity in cell culture in combination with Paclitaxel. It inhibits tumor growth in athymic nude mice in a dose-responsive manner.

  • High-affinity PPARγ agonist
  • Upregulates p21WAF1/CIP1 cell cycle kinase inhibitor
  • Shows additive antiproliferative activity with Paclitaxel
  • Inhibits tumor growth in vivo

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.